Comparative field evaluation of marbofloxacin tablets in the treatment of feline upper respiratory infections
- 28 June 1998
- journal article
- Published by Wiley in Journal of Small Animal Practice
- Vol. 39 (6), 286-289
- https://doi.org/10.1111/j.1748-5827.1998.tb03652.x
Abstract
One hundred and three cats presenting with clinical signs of feline acute upper respiratory Infection were selected from Belgium, France and the Netherlands In a randomised comparative field trial. Each cat underwent a bacteriological examination before treatment (day 0) and received either marbofloxacin, at a dosage of 2 mg/kg once daily for five days, or amoxycillln‐clavulanic acid (ACA) at a dosage of 12·5 mg/kg twice dally for five days. Clinical examinations were performed on days 2, 5 and 14. Pasteurella species were cultured in one‐third of the samples. The other main bacteria isolated were Streptococcaceae, Enterobacterlaceae and Staphylococcaceae. Response rates (cures + improvements) to treatment on day 5 were 87·8 vs 77·8 per cent for marbofloxacin and ACA, respectively. A few mild side‐effects (diarrhoea, vomiting) were recorded with both drugs.Keywords
This publication has 7 references indexed in Scilit:
- Feline infectious upper respiratory diseaseIn Practice, 1995
- Antibacterial activity of marbofloxacin. A new fluoroquinolone for veterinary use against canine and feline isolatesJournal of Veterinary Pharmacology and Therapeutics, 1995
- Seroprevalence and isolation rate of Bordetella bronchiseptica in cats in the UKPublished by Wiley ,1994
- Role of Infectious Agents in Respiratory DiseaseVeterinary Clinics of North America: Small Animal Practice, 1993
- Isolation of B bronchiseptica from kittens with pneumonia in a breeding catteryPublished by Wiley ,1991
- Evaluation of a monoclonal antibody based ELISA for detection of feline Chlamydia psittaciVeterinary Record, 1986
- Infectious Respiratory DiseaseVeterinary Clinics of North America: Small Animal Practice, 1984